Chapter 7

FISH

Graeme N. Forrest

Graeme N. Forrest

Portland Veterans Affairs Medical Center and Oregon Health and Science University, Department of Infectious Diseases, 3710 SW US Veterans Hospital Rd, P3-ID, Portland, OR 97239, USA

Search for more papers by this author
Jwan Mohammadi

Jwan Mohammadi

Oregon Health and Science University, Department of Infectious Diseases, 3181 SW Sam Jackson Park Rd, L-457, Portland, OR 97239, USA

Search for more papers by this author
Shahrzad Mohammadi

Shahrzad Mohammadi

Portland Veterans Affairs Medical Center and Oregon Health and Science University, Department of Infectious Diseases, 3710 SW US Veterans Hospital Rd, P3-ID, Portland, OR 97239, USA

Search for more papers by this author
First published: 27 February 2015

Summary

Fluorescence in situ hybridization (FISH) probes were first developed to locate the positions of specific DNA sequences on chromosomes. This chapter presents the current FISH tests that are available, their future directions, and their role and impact in clinical practice and patient care. Despite FISH tests being commercially available for almost a decade now, there remains very little prospective clinical data on the impact of these tests in the literature. There are currently two commercially available FISH techniques available for microbiology laboratories namely peptide nucleic acid fluorescence in situ hybridization (PNA FISH) and molecular beacons-based (bbFISH). There is now over a decade's clinical data on the use of PNA FISH in the clinical setting with different pathogens and countries. Most of the data is with blood stream infections, but increasingly there is new data on its use from other sites of infection.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.